O-2113

O-2113
(IUPAC) ime
	(6aR,10aR)-3-(1-etansulfonilamino-5-metil-heksan-5-il)-6a,7,10,10a-tetrahidro-6,6,9-trimetil-6H-dibenzo[b,d]piran
Klinički podaci
Identifikatori
ATC kod	nije dodeljen
PubChem	11775273
ChemSpider	26333261
Hemijski podaci
Formula	C25H39NO4S
Mol. masa	449,645 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C25H39NO4S/c1-7-31(28,29)26-13-9-8-12-24(3,4)18-15-21(27)23-19-14-17(2)10-11-20(19)25(5,6)30-22(23)16-18/h10,15-16,19-20,26-27H,7-9,11-14H2,1-6H3/t19-,20-/m1/s1 ; Key: UMJJTCXPFDHKGJ-WOJBJXKFSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

O-2113 je lek, koji je klasični kanabinoidni derivat. On može da deluje kao potentan agonist za kanabinoidne receptore, proizvodeći sedaciju, hipotermiju i analgeziju u životinjskim studijama.^[4]

Povezano

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Martin, et al. Sulfonamide Cannabinoid Agonists and Antagonist. US Patent 7279500, Oct 9 2007

	Portal Medicina
	Portal Hemija